Menu
GWAS Study

A Protective Role of Low Polygenic Risk Score in Healthy Individuals Carrying Attention-Deficit/Hyperactivity Disorder-Associated Copy Number Variations.

Chang X, Qu H, Liu Y et al.

37865391 PubMed ID
GWAS Study Type
4800 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CX
Chang X
QH
Qu H
LY
Liu Y
GJ
Glessner J
HH
Hakonarson H
Chapter II

Abstract

Summary of the research findings

Previous studies have implicated both rare copy number variations (CNVs) and common variants in liability for attention-deficit/hyperactivity disorder (ADHD). However, how common and rare genetic variants jointly contribute to individual liability requires further investigation in larger cohorts.

1,200 African American cases, 3,600 African American controls

Chapter III

Study Statistics

Key metrics and study information

4800
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.